Fumie Nakashima
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications 4
-
- Eicosanoids and Hypertension Pharmacology 3
-
- Advanced Glycation End Products research 3
-
- Eicosanoids and Hypertension Pharmacology 3
-
- Inflammatory mediators and NSAID effects 4
-
- Genomics, phytochemicals, and oxidative stress 3
- Protein Interaction Studies and Fluorescence Analysis 3
- Natural product bioactivities and synthesis 2
-
- Drug Transport and Resistance Mechanisms 2
- Co-authors
- Takahiro ShibataKôji UchidaClaus SchneiderRyosuke KikuchiPaula B. LuisJuan Antonio Giménez‐BastidaTadashi MatsushitaIsao Ishii
- Journals
- Journal of Biological Chemistry (4 papers)SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)
- Partner nations
- JapanUnited StatesSpain
In The Last Decade
Fumie Nakashima
20 papers receiving 369 citations
Peers
Comparison fields: 5 of 86
- Molecular Medicine 51
- Biochemistry 31
- Clinical Biochemistry 26
- Biochemistry 22
- Pharmacology 22
Countries citing papers authored by Fumie Nakashima
This map shows the geographic impact of Fumie Nakashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumie Nakashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumie Nakashima more than expected).
Fields of papers citing papers by Fumie Nakashima
This network shows the impact of papers produced by Fumie Nakashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumie Nakashima. The network helps show where Fumie Nakashima may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fumie Nakashima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 3 | |
| 8 | 2021 | 7 | |
| 9 | 2020 | 29 | |
| 10 | 2019 | 22 | |
| 11 | 2019 | 1 | |
| 12 | 2019 | 14 | |
| 13 | 2018 | 73 | |
| 14 | 2017 | 23 | |
| 15 | 2017 | 26 | |
| 16 | 2016 | 17 | |
| 17 | 2016 | 24 | |
| 18 | 2016 | 29 | |
| 19 | 2014 | 46 | |
| 20 | 2014 | 20 |
About Fumie Nakashima
Fumie Nakashima is a scholar working on Molecular Medicine, Biochemistry and Clinical Biochemistry, having authored 23 papers that have together received 374 indexed citations. Recurring topics across this work include Curcumin's Biomedical Applications (4 papers), Inflammatory mediators and NSAID effects (4 papers), Genomics, phytochemicals, and oxidative stress (3 papers), Eicosanoids and Hypertension Pharmacology (3 papers), Advanced Glycation End Products research (3 papers), Protein Interaction Studies and Fluorescence Analysis (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and Natural product bioactivities and synthesis (2 papers). The work is most often cited by research in Molecular Medicine (51 citations), Biochemistry (31 citations) and Clinical Biochemistry (26 citations). Fumie Nakashima has collaborated with scholars based in Japan, United States and Spain. Frequent co-authors include Takahiro Shibata, Kôji Uchida, Claus Schneider, Ryosuke Kikuchi, Paula B. Luis, Juan Antonio Giménez‐Bastida, Tadashi Matsushita, Isao Ishii, Kohei Kamiya and Jun Yoshitake. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.